Clinical Trial

Sentinel Lymph Node Biopsy in Early-Stage Ovarian Cancer

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 25, 2024 (before its estimated October 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
The primary goal of this prospective study is to define the efficacy of the sentinel lymph node biopsy (SLNB) procedure by comparing it to the results obtained from systematic lymphadenectomy, each performed in participants with a suspicious adnexal mass for early-stage ovarian cancer.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-06-25.
Trial Details
NCT Number NCT05927818
Lead Sponsor Istanbul University
Conditions Sentinel Lymph Node, Ovarian Carcinoma
Enrollment 100 participants
Start Date 2023-04-15
Primary Completion 2025-10-15 (estimated)
Study Completion 2026-01-15 (estimated)
Updated on ClinicalTrials.gov 2024-11-25